Replies to post #31940 on Kiwa Bio-Tech Products Group Corp (fka KWBT)

[Szechuan20]

For the year ended 12.31.19, the company lost $7,000,000.

Net Loss $7,000,000

Add Back:

Toxic Interest Gone +3,944,000

Loss Sale Of Sub Gone +3,527,254

Net Profit Restated $471,254

Clean Up GP% +1,200,000

Net Profit Easily Could have been $1,671,254

O/S Shares 300,000,000

EPS $0.0056 x 20 = $0.11 FMV

My guess is management knew the year was going to show a loss, so what do they typically do, push all the inventory and negative adjustments into that year.

[operating_line]

Revenue will bring cash in the company front door and is a clear sign of business activity. Management plan to use some of it to pay expensive debt in cash. Profit is what is left after the business expenses, including debt. A good CEO grows the company first to gain market share. I am hoping for profits in China, as are Amex, Blackrock, Goldman Sachs:

"The opening to card companies is part of a broader plan by China to give access to its markets, which also includes insurance, asset management and investment banking. BlackRock Inc. and Goldman Sachs Group Inc. are among a bevy of firms that are preparing to pile in full bore to capture profits from China’s fast-growing wealth."

https://www.bloomberg.com/news/articles/2020-06-13/amex-wins-card-clearing-license-for-china-s-27-trillion-market